Recurrence of supramolecular synthons in 5-fluorocytosine co-crystals with dicarboxylic acids (2012)
- Authors:
- Autor USP: ELLENA, JAVIER ALCIDES - IFSC
- Unidade: IFSC
- Subjects: PLANEJAMENTO DE FÁRMACOS; CRISTALOGRAFIA
- Language: Inglês
- Imprenta:
- Publisher: International Union of Crystallography - IUCr
- Publisher place: Chester
- Date published: 2012
- Source:
- Título do periódico: Programa y Resúmenes
- Conference titles: Reunión Anual de la Asociación Argentina de Cristalografia - AACr
-
ABNT
ELLENA, Javier e PEPINO, Rebeka O. e SILVA, Cecília C. P. Recurrence of supramolecular synthons in 5-fluorocytosine co-crystals with dicarboxylic acids. 2012, Anais.. Chester: International Union of Crystallography - IUCr, 2012. . Acesso em: 30 set. 2024. -
APA
Ellena, J., Pepino, R. O., & Silva, C. C. P. (2012). Recurrence of supramolecular synthons in 5-fluorocytosine co-crystals with dicarboxylic acids. In Programa y Resúmenes. Chester: International Union of Crystallography - IUCr. -
NLM
Ellena J, Pepino RO, Silva CCP. Recurrence of supramolecular synthons in 5-fluorocytosine co-crystals with dicarboxylic acids. Programa y Resúmenes. 2012 ;[citado 2024 set. 30 ] -
Vancouver
Ellena J, Pepino RO, Silva CCP. Recurrence of supramolecular synthons in 5-fluorocytosine co-crystals with dicarboxylic acids. Programa y Resúmenes. 2012 ;[citado 2024 set. 30 ] - Acta Crystallographica E
- LACA School on Small Molecule Crystallography, 3
- International Conference on Artificial Intelligence and Energy System - ICAIES, 2
- Studies towards two novel Ni(II) thiosemicarbazone-based complexes: pharmacological properties and protein-ligand interactions assessment
- Ruthenium/nitrosyl/amino acids complexes inhibit MDA-MB-231 breast cancer tumor cell growth and migration
- Partial magnetic ordering and crystal structure of the ludwigities 'Co IND.2'Fe'O IND.2'B'O IND.3' and 'Ni IND.2'Fe'O IND.2'B'O IND.3'
- Antihypertensives Drug-Drug co-crystals: drug combination for the treatment of covid sequels
- Polymorphisms in active pharmaceutical ingredients: structural and vibrational investigations
- Polymorphisms in active pharmaceutical ingredients: Oxcarbazepine and Deflazacort
- Determinação experimental e teórica do espectro vibracional do produto de decomposição da oxcarbazepina
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
